Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Nerve action potential amplitude, a robust marker of diabetic peripheral neuropathy.

Monlun M, Hugo M, Blanco L, Mohammedi K, Ahdab R, Alexandre L, Poirot-Mazeres S, Rajaobelina K, Rigalleau V.

Diabet Med. 2018 Oct;35(10):1460-1461. doi: 10.1111/dme.13690. No abstract available.

PMID:
29791761
2.

Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy.

Wilson JR, Stittsworth JD Jr, Kadir A, Fisher MA.

Muscle Nerve. 1998 Sep;21(9):1228-30.

PMID:
9703455
3.

[Interrelationship among nerve conduction velocity, amplitudes of compound muscle and compound nerve action potentials in diabetic neuropathy].

Hasegawa O, Matsumoto S, Iino M, Mori I, Arita T, Baba Y.

No To Shinkei. 1999 Oct;51(10):863-6. Japanese.

PMID:
10553586
4.

Sensory nerve conduction in diabetes mellitus and diabetic neuropathy.

Sathiamoorthy A, Reddy LP, Sathiamoorthy SS, Balachander J, Chandrasekar S.

Indian J Physiol Pharmacol. 1983 Apr-Jun;27(2):118-22.

PMID:
6885123
5.

Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.

Turgut N, Karasalihoglu S, Kücükugurluoglu Y, Balci K, Ekuklu G, Tütüncüler F.

Clin Neurophysiol. 2004 Jun;115(6):1452-6.

PMID:
15134714
7.

Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.

Tamura N, Kuwabara S, Misawa S, Mori M, Nakata M, Hattori T.

Clin Neurophysiol. 2005 Oct;116(10):2330-3.

PMID:
16122982
8.

Validity of the neurological examination in diagnosing diabetic peripheral neuropathy.

Höliner I, Haslinger V, Lütschg J, Müller G, Barbarini DS, Fussenegger J, Zanier U, Saely CH, Drexel H, Simma B.

Pediatr Neurol. 2013 Sep;49(3):171-7. doi: 10.1016/j.pediatrneurol.2013.03.014. Epub 2013 Jul 4.

PMID:
23831248
9.

[Correlation between vibratory detection threshold and conduction study of sural nerve in diabetic patients].

Ohnishi A, Yamamoto T, Murai Y, Ikeda M, Sugimoto H, Miyoshi T.

J UOEH. 1989 Dec 1;11(4):425-8. Japanese.

PMID:
2609039
10.

Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients.

Uluc K, Isak B, Borucu D, Temucin CM, Cetinkaya Y, Koytak PK, Tanridag T, Us O.

Clin Neurophysiol. 2008 Apr;119(4):880-5. doi: 10.1016/j.clinph.2008.01.001. Epub 2008 Mar 4.

PMID:
18291716
11.

Piroxicam may reduce the rate of progression of experimental diabetic neuropathy.

Parry GJ, Kozu H.

Neurology. 1990 Sep;40(9):1446-9.

PMID:
2392233
12.
13.

Peripheral neuropathy and refractory periods of motor nerves.

Meyer M.

Neurol Neurochir Pol. 1986 Mar-Apr;20(2):112-5. No abstract available.

PMID:
3022174
14.

The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats.

Robertson S, Cameron NE, Cotter MA.

Diabetologia. 1992 Dec;35(12):1113-7.

PMID:
1478362
15.

The medial plantar and medial peroneal cutaneous nerve conduction studies for diabetic polyneuropathy.

Altun Y, Demirkol A, Tumay Y, Ekmekci K, Unsal I, Koyluoglu AC, Ozkul Y.

Neurol Sci. 2011 Oct;32(5):849-54. doi: 10.1007/s10072-011-0669-2. Epub 2011 Jul 1.

PMID:
21720897
16.

Effect of gangliosides on nerve conduction velocity during diabetic neuropathy in the rat.

Spüler M, Dimpfel W, Tüllner HU.

Arch Int Pharmacodyn Ther. 1987 Jun;287(2):211-23.

PMID:
3307667
17.
18.

Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy.

Barnett C, Perkins BA, Ngo M, Todorov S, Leung R, Bril V.

Muscle Nerve. 2012 Jan;45(1):126-7. doi: 10.1002/mus.22166.

PMID:
22190318
19.
20.

Correlation of near-nerve sural conduction and quantified sensory testing in patients with diabetic neuropathy.

Horowitz SH.

Muscle Nerve. 1995 Oct;18(10):1202-4. No abstract available.

PMID:
7659116

Supplemental Content

Support Center